SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Wanwisa Dejnirattisai(Hammersmith Hospital), Malcolm G. Semple(University of Liverpool), Síle A. Johnson(Medawar Building for Pathogen Research), Ori Avinoam(Weizmann Institute of Science), Gaurav Kwatra(South African Medical Research Council), Aekkachai Tuekprakhon(University of Birmingham), Cristiano Fernandes da Costa(Fundação de Medicina Tropical), Peter Openshaw(Imperial College London), Helen M. E. Duyvesteyn(Centre for Human Genetics), Piyada Supasa(University of Oxford), Tariq Malik(Public Health England), Ali Amini(University of Oxford), Marilda Mendonça Siqueira(Fundação Oswaldo Cruz), Marta C. Nunes(Université Claude Bernard Lyon 1), Felipe Gomes Naveca(Fundação Oswaldo Cruz), J. Kenneth Baillie(NHS Lothian), Chris Mason(Oxford University Hospitals NHS Trust), Helen M. Ginn(Instruct-ERIC), Aiste Dijokaite-Guraliuc(Centre for Human Genetics), Rungtiwa Nutalai(Centre for Human Genetics), Parvinder K. Aley(University of Oxford), Christina Dold(University of Oxford), Donal Skelly(John Radcliffe Hospital), Daming Zhou(Centre for Human Genetics), Suman Khan(Weizmann Institute of Science), Vicky L. Baillie(South African Medical Research Council), Alexander J. Mentzer(Centre for Human Genetics), Paola Cristina Resende(Fundação Oswaldo Cruz), Adam Bellass(University Hospitals of Leicester NHS Trust), Daniel Jenkin(University of Oxford), Sue Ann Costa Clemens(The George Institute for Global Health), Daniel Pan(University of Leicester), Fernanda Nascimento, Natali Serafin(South African Medical Research Council), Alex Pauvolid‐Corrêa(Fundação Oswaldo Cruz), Jiandong Huo(Guangzhou Experimental Station), Nicola Omo-Dare(University Hospitals of Leicester NHS Trust), Shabir A. Madhi(University of the Witwatersrand), David Koeckerling(University of Oxford), Sandra Adele(Medawar Building for Pathogen Research), Jiří Zahradník(Charles University), Amy Flaxman(University of Oxford), Merryn Voysey(Stratasys (Israel)), Valdinete Alves do Nascimento, Beibei Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Chang Liu(Paul Scherrer Institute), Kelly da Silva(South African Medical Research Council), Thomas Ritter(Oxford University Hospitals NHS Trust), Mohammad W. Bahar(Centre for Human Genetics), Sara Assadi(University Hospitals of Leicester NHS Trust)
Cited by 1,017
Related Papers
An atlas of active enhancers across human cell types and tissues
|Nature|2014|2.8k
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k